Syncope caused by iatrogenic hyperkalemia

Journal of Cardiovascular Medicine

Volumn 10, Issue 1, 2009, Pages 72-74

  Giancaspro, Giuseppe ^a,b   Suppa, Marianna ^a   Genuini, Igino ^a   Caselli, Stefano ^a   Fedele, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Angiotensin receptor blockers; Arrythmias; Hyperkalemia; Syncope

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CARBAMAZEPINE; FUROSEMIDE; ISOTONIC SOLUTION; LOSARTAN; POLYSTYRENESULFONATE SODIUM;

AGED; ARTICLE; BRADYCARDIA; CARDIOMEGALY; CASE REPORT; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEAD INJURY; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART PACING; HISTORY; HUMAN; HYPERKALEMIA; HYPERTENSION; LABORATORY TEST; MITRAL VALVE REGURGITATION; NEPHRECTOMY; NEPHROLITHIASIS; P WAVE; PHYSICAL EXAMINATION; POTASSIUM RESTRICTION; QRS COMPLEX; RISK; SINUS NODE; SINUS RHYTHM; SUDDEN DEATH; SYNCOPE; SYSTOLE; T WAVE; TRICUSPID VALVE REGURGITATION; TRIGEMINUS NEURALGIA; VITAL SIGN;

AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CATION EXCHANGE RESINS; COMBINED MODALITY THERAPY; DIURETICS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERKALEMIA; IATROGENIC DISEASE; LOSARTAN; SYNCOPE; TREATMENT OUTCOME;

EID: 67650921112     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328319bfa4     Document Type: Article

References (7)

1. Ettinger PO, Regan TJ, Oldewurtel HA. Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 1974; 88:360-371.
2. Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, Handley AJ, et al. European Resuscitation Council guidelines for resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 2005; 67 (Suppl 1):S135-S170.
3. Levey AS. Nondiabetic kidney disease. N Engl J Med 2002; 347:1505-1511.
4. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Circulation 2006; 114:1083-1087.
5. Palmer BF. Managing hyperkalemia caused by inhibitors of the reninangiotensin-aldosterone system. N Engl J Med 2004; 351:585-592.
6. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004; 351:543-551.
7. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334:1448-1460.